$9.79
▼ -3.8% Today
as of Jul 22, 09:10 ET
Last 30 days
Recent Press Releases & News
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Turn Therapeutics’ stock jumps on AD data and trial expansion
Turn Therapeutics Completes Interim Phase 2 Review; Expands GX-03 Study in Atopic Dermatitis
Overview
52-week range
$2.57
$26
30% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
+2.4%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.03 | — | — | — | +2.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.07 | — | — | — | — | financials |
| Mon Mar 31, 2025 | Mar 2025 | $-0.01 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.03 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | — | — |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | $-1M | — | $-2M | $-384,997 | — | $-672,992 |
| Net income | $-970,972 | — | $-2M | $-328,547 | — | $-666,442 |
| EPS (diluted) | $-0.03 | — | $-0.07 | $-0.01 | — | $-0.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $4M | $513,695 | — | — | $498,286 |
| Inventory | — | — | — | — | — | — |
| Total current assets | $11M | $5M | $3M | — | $1M | — |
| Total assets | $19M | $12M | $4M | — | $2M | — |
| Long-term debt | $6M | — | — | — | — | — |
| Total liabilities | $13M | $7M | $4M | — | $2M | — |
| Total equity | $6M | $5M | $504,019 | $818,710 | $-177,432 | $-414,299 |
Implied volatility — last 90 days
No IV snapshots yet for TTRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.